---
title: "Imunon, Inc. (IMNN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/IMNN.US.md"
symbol: "IMNN.US"
name: "Imunon, Inc."
industry: "生物技术"
---

# Imunon, Inc. (IMNN.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [imunon.com](https://imunon.com) |

## Company Profile

Imunon, Inc.是一家临床阶段的生物技术公司，专注于开发免疫疗法和疫苗。该公司的主要临床项目是 IMNN-001，这是一种基于 DNA 的免疫疗法，用于局部治疗卵巢癌，目前处于第二阶段临床开发中。其临床前阶段的产品包括 IMNN-101，一种 COVID-19 加强疫苗；IMNN-102，用于治疗拉沙病毒；以及 IMNN-201，一种针对黑色素瘤的 Trp2 肿瘤相关抗原癌症疫苗。此外，该公司还开发了四种模式的非病毒 DNA 技术，例如 TheraPlas，用于编码治疗实体肿瘤的蛋白质和细胞因子；以及 PlaCCine，用于编码能够引发强烈免疫反应的病毒抗原

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.77 | 171/606 | - | - | - |
| PB | 2.71 | 210/606 | 22.65 | 3.79 | 2.89 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-06T05:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 60% |
| Overweight | 0 | 0% |
| Hold | 1 | 20% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.25 |
| Highest Target | 45.00 |
| Lowest Target | 12.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/IMNN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/IMNN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/IMNN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.